Heterogeneity of colorectal cancers and extraction of discriminator gene signatures for personalized prediction of prognosis

International Journal of Oncology

Volumn 39, Issue 4, 2011, Pages 781-789

  Miyake, M ^a   Takemasa, Ichiro ^a   Matoba, R ^b   Tanino, M ^b   Niijima, S ^c   Ikeda, M ^a   Yamamoto, H ^a   Sekimoto, M ^a   Kuhara, S ^c   Okayama, T ^d   Monden, M ^a   Matsubara, K ^b   Mori, M ^a  

^a OSAKA UNIVERSITY   (Japan)

^b DNA CHIP RESEARCH INC   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d Bits Co Ltd   (Japan)

Author keywords

Colorectal cancer; Expression profile; Recurrence

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENETIC HETEROGENEITY; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79960871662     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1092     Document Type: Article

References (26)

1. Pisani P, Parkin DM and Ferlay J: Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55: 891-903, 1993. (Pubitemid 24005331)
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: statistics, 2009. CA J Clin 59: 225-249, 2009.
3. Andre T, Boni C, Mounedji-Boudiaf L, et al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343-2351, 2004. (Pubitemid 38702845)
4. Benson AB III, Schrag D, Somerfield MR, et al: American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Oncol 22: 3408-3419, 2004. (Pubitemid 41103700)
5. Figueredo A, Charette ML, Maroun J, Brouwers MC and Zuraw L: Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol 22: 3395-3407, 2004. (Pubitemid 41103699)
6. Cronin M, Pho M, Dutta D, et al: Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am J Pathol 164: 35-42, 2004. (Pubitemid 38364587)
7. Van't Veer LJ, Dai H, van de Vijver MJ, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536, 2002. (Pubitemid 34130608)
8. Van de Vijver MJ, He YD, van't Veer LJ, et al: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009, 2002. (Pubitemid 35461656)
9. Arango D, Laiho P, Kokko A, et al: Gene-expression profiling predicts recurrence in Dukes' colorectal cancer. Gastroenterology 129: 874-884, 2005. (Pubitemid 41242680)
10. Barrier A, Boelle PY, Roser F, et al: Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol 24: 4685-4691, 2006. (Pubitemid 46630932)
11. Eschrich S, Yang I, Bloom G, et al: Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 23: 3526-3535, 2005.
12. Fan J, Peng Z, Zhou C, et al: Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis. Cancer 113: 266-275, 2008.
13. Fritzmann J, Morkel M, Besser D, et al: A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology 137: 165-175, 2009.
14. Jorissen RN, Gibbs P, Christie M, et al: Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage and Colorectal Cancer. Clin Cancer Res 15: 7642-7651, 2009.
15. Ki DH, Jeung HC, Park CH, et al: Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer 121: 2005-2012, 2007.
16. Kleivi K, Lind GE, Diep CB, et al: Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Mol Cancer 6: 2, 2007.
17. Shi L, Reid LH, Jones WD, et al: The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24: 1151-1161, 2006. (Pubitemid 44359727)
18. Shih W, Chetty R and Tsao MS: Expression profiling by microarrays in colorectal cancer (Review). Oncol Rep 13: 517-524, 2005.
19. Wang Y, Jatkoe T, Zhang et al: Gene expression profiles and molecular markers to predict recurrence of Dukes' colon cancer. J Clin Oncol 22: 1564-1571, 2004. (Pubitemid 41079793)
20. Watanabe T, Kobunai T, Sakamoto E, et al: Gene expression signature for recurrence in stage III colorectal cancers. Cancer 115: 283-292, 2009.
21. Yamasaki M, Takemasa I, Komori T, et al: The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. Int J Oncol 30: 129-138, 2007.
22. Kopetz S and Abbruzzese JL: Barriers to Integrating Gene Profiling for Stage II Colon Cancer. Clin Res 15: 7451-7452, 2009.
23. Tan PK, Downey TJ, Spitznagel EL, et al: Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res 31: 5676-5684, 2003. (Pubitemid 37441938)
24. Troyanskaya O, Cantor M, Sherlock G, et al: Missing value estimation methods for DNA microarrays. Bioinformatics 17: 520-525, 2001. (Pubitemid 32600498)
25. Dudoit S, Fridyand J and Speed TP: Comparison of discrimination methods for the classification of tumors using gene expression data. J Am Stat Assoc 97: 77-87, 2002.
26. Weiser MR, Landmann RG, Kattan MW, et al: Individualized prediction of colon cancer recurrence using a nomogram. J Oncol 26: 380-385, 2008. (Pubitemid 351171688)